Mar 18th: CureBay, a hybrid healthcare company focused on expanding access to quality care across underserved communities, has acquired the pharmacy distribution business of Saveo Healthtech. CureBay is backed by Bertelsmann India Investments, Elevar Equity, and British International Investment (BII). Saveo’s Pharmacy distribution business is a technology-enabled B2B pharma distribution company serving over 10,000 retail pharmacies across Karnataka, Telangana, Andhra Pradesh and Tamil Nadu, with operational hubs in Bengaluru and Hyderabad.
This acquisition brings into CureBay an operational pharma distribution network, including physical hubs, procurement capabilities, digital ordering systems and an experienced distribution team. It also adds Saveo’s operating playbooks, procurement relationships and deep distribution expertise, strengthening CureBay’s ability to expand medicine distribution as it grows into new geographies.
CureBay currently operates over 190 eClinics, serving more than 10 lakh patients across 15,000+ villages. The company’s expansion has been anchored in a financially disciplined cluster-based model, with two profitable circles across Odisha and neighbouring markets..The combined model enables tighter procurement, stronger generics programs, improved inventory visibility and faster fulfilment cycles. With structured demand planning and disciplined working capital management, CureBay aims to reduce stock-outs and improve availability across chronic and essential therapy categories.
Priyadarshi Mohapatra, Founder and CEO, CureBay, said, “Medicines are central to continuity of care. By acquiring Saveo’s pharmacy distribution business, we are strengthening our ability to ensure consistent and affordable access to medicines across the communities we serve. We see significant value in Saveo’s operating processes, procurement depth and experienced team. This integration accelerates our pharmacy roadmap, enables us to scale faster and improves customer satisfaction by reducing supply gaps and enhancing reliability.”
Saveo’s existing pharmacy partners will continue operating within the integrated network, benefiting from expanded sourcing capabilities and CureBay’s growing healthcare footprint. At the same time, CureBay’s clinics and partner pharmacies will gain access to a more robust and reliable distribution backbone.
As part of the integration, Amit Kumar, Co-founder and CTO at Saveo, will lead Pharmacy Technology at CureBay, while Deepak Tiwary, Head of B2R at Saveo, will oversee Pharmacy Operations, supporting the company’s next phase of expansion.
Amit Kumar, Co-Founder, Saveo, said, “Saveo has built a disciplined, technology-first distribution business designed to serve pharmacies efficiently. By becoming part of CureBay, our platform, processes and team will now support a broader healthcare network and help strengthen medicine access at scale.”
This acquisition marks an important step in CureBay’s long-term strategy to build an integrated healthcare ecosystem where consultations, diagnostics and pharmacy services work seamlessly together, delivering reliable, affordable and end-to-end care across underserved regions of India.
